...well as its route of administration.Aurinia’s drug will also enter a marketplace in which Benlysta belimumab...

...By BioCentury Staff FDA expands Benlysta label to include lupus nephritisFDA approved Benlysta belimumab from GlaxoSmithKline...
...Programmed cell death 1 PD-L1 (B7-H1; CD274) – Programmed cell death 1 ligand 1 BC Staff Benlysta, belimumab...

...patient recruitment have slowed progress in lupus. Benlysta belimumab...

...that although lupus nephritis is a complication of systemic lupus erythematosis (SLE), for which Benlysta belimumab...
...looking for an absolute benefit of 10%. On BLISS-LN’s primary endpoint, significantly more patients receiving belimumab...
...the treatment landscape (see “Three Late-Stage Wins” ). Targets BLyS (BAFF; TNFSF13B) Paul Bonanos, Associate Editor Benlysta, belimumab...

...plc (LSE:GSK; NYSE:GSK) is on track for regulatory submissions in 1H20 seeking to expand Benlysta belimumab’s...

...and TNFSF13 to impact development and survival of plasma cells and mature B cells. Benlysta belimumab...

...first-line advanced renal cell carcinoma in combination with Inlyta axitinib from Pfizer Inc. (NYSE:PFE); Benlysta belimumab...

...the second new medicine for lupus in over 60 years. In 2011, FDA approved Benlysta belimumab...

...plaque psoriasis. Benlysta approved in China for lupus NMPA approved the IV formulation of Benlysta belimumab...

...I diabetes. Benlysta first approved drug in U.S. for children with lupus FDA approved Benlysta belimumab...